Revolutionizing the Delivery of Health Care: A Health Policy and Bioethics Consortium
The United States spends more on health care than any other country, but high spending often does not translate into improved outcomes, particularly in comparison to health systems in other countries.
Are there policies that could help redirect the U.S. health care system? What are the appropriate goals of the health care system?
Two health policy experts discussed how quality, efficiency, and responsiveness can be emphasized in the U.S. health system.
Donald M. Berwick, MD, MPP, President Emeritus and Senior Fellow, Institute for Healthcare Improvement and Former Administrator, Centers for Medicare and Medicaid Services
Rushika Fernandopulle, MD, MPP, CEO, Iora Health
This event was free and open to the public.
Learn more about the Health Policy and Bioethics Consortia.
The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.